Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01117571 · ClinicalTrials.gov registry record
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
A clinical trial, sponsored by Restor3D.
- Terminated
- Registry status
- 120
- Enrollment target
NCT01117571: Clinical Trial study, sponsored by Restor3D.
NCT01117571 is a clinical trial that was terminated before completion, run by Restor3D. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01117571 was terminated before completion, sponsored by Restor3D.
- TERMINATED
- Registry status
- 120 participants
- Enrollment target
Study Summary
Study is prospective and multi-center. Study will include 100 to 200 patients across up to 20 sites.The study sites will be located in the United States.The study objective is to evaluate the safety and performance of the ConforMIS iUni® Unicompartmental Knee Resurfacing Device in patients with single compartment osteoarthritis.
Primary Outcome
to assess knee pain and function
Interventions
- DEVICE iUni® Unicompartmental Knee Resurfacing Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2010-04 |
| Est. Completion | 2023-01-10 |
Why NCT01117571 stopped before completion
NCT01117571 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which iUni® Unicompartmental Knee Resurfacing Device is the first listed.
NCT01117571 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01117571 about?
NCT01117571 is a clinical study titled "Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant". Study is prospective and multi-center. Study will include 100 to 200 patients across up to 20 sites.The study sites will be located in the United States.The study objective is to evaluate the safety and performance of the ConforMIS iUni® Unicompartmental Knee Resurfacing Device in patients with sing...
What is the current status of trial NCT01117571?
This trial is currently terminated. The enrollment target is 120 participants. The study started on 2010-04. Estimated completion is 2023-01-10.
What interventions are being tested in trial NCT01117571?
The interventions under investigation include: iUni® Unicompartmental Knee Resurfacing Device (DEVICE).
Who is sponsoring clinical trial NCT01117571?
This trial is sponsored by Restor3D, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia